| 15-May-2023 | D | Please be informed that the Board of Directors has at its Meeting held today, i.e., May 15, 2023, recommended a final dividend of Rs. 35/-per equity share of Rs. 10/- each (350%) and a special dividend of Rs. 5/- per equity share of Rs. 10/- each (50%) in view of the gain on sale of business undertaking at Thane, aggregating to total dividend of Rs. 40/- per equity share of Rs. 10/- each (400%) for the financial year ended March 31, 2023. The said final dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 16, 2023.
| 11-Aug-2023 | |
| 15-May-2023 | D | Please be informed that the Board of Directors has at its Meeting held today, i.e., May 15, 2023, recommended a final dividend of Rs. 35/-per equity share of Rs. 10/- each (350%) and a special dividend of Rs. 5/- per equity share of Rs. 10/- each (50%) in view of the gain on sale of business undertaking at Thane, aggregating to total dividend of Rs. 40/- per equity share of Rs. 10/- each (400%) for the financial year ended March 31, 2023. The said final dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 16, 2023.
| 11-Aug-2023 | |
| 06-Sep-2022 | D | The Board of Directors at its meeting held today, i.e., September 6, 2022 has declared an Interim (Special) Dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) for the financial year ending March 31, 2023, in view of the gain on account of sale of Upjohn Business to Mylan Pharmaceuticals Private Limited. The said Board Meeting commenced at 11.45 a.m. and concluded at 12.40 p.m. The said Interim Dividend will be paid to the eligible Members of the Company on or before Friday, September 30, 2022. We further inform you that the Record Date for the payment of aforementioned Dividend of Rs. 30/- (300%) per equity share is Tuesday, September 20, 2022.
| 19-Sep-2022 | |
| 20-May-2022 | D | The Board of Directors have at its Meeting held today, i.e., May 20, 2022, recommended a dividend of Rs. 35/- per equity share of Rs. 10/- each {350%) for the financial year ended March 31, 2022. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 23, 2022. | 18-Aug-2022 | |
| 26-May-2021 | D | Please be informed that the Board of Directors of the Company has recommended a normal dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) and a special dividend of Rs. 5/- per equity share of Rs. 10/- each (50%), aggregating to total dividend of Rs. 35/- per equity share of Rs. 10/- each (350%) for the year ended March 31, 2021. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 15, 2021. | 11-Aug-2021 | |
| 26-May-2021 | D | Please be informed that the Board of Directors of the Company has recommended a normal dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) and a special dividend of Rs. 5/- per equity share of Rs. 10/- each (50%), aggregating to total dividend of Rs. 35/- per equity share of Rs. 10/- each (350%) for the year ended March 31, 2021. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 15, 2021. | 11-Aug-2021 | |
| 15-Jun-2020 | D | Audited financial results and Audit Report for the financial year ended March 31, 2020.
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 15, 2020, inter alia, have recommended a final dividend of Rs. 10 per equity share of Rs. 10 each (100%) for the financial year ended March 31, 2020. The said final dividend, if declared at the ensuing General Meeting of the Company shall be paid on or before September 30, 2020.
| 27-Aug-2020 | |
| 27-Apr-2020 | D | The Board of Directors of the Company at their Meeting via Video Conference held today i.e. April 27, 2020 at 12.00 noon and concluded at 1.20 p.m. have declared a Special Dividend of Rs. 320/- per equity share of Rs. 10/- each (3200% ) for the financial year ended March 31, 2020.
The said Special Dividend will be paid to the eligible Members of the Company(whose names appear in the Register of Members as on the Record Date i.e. Friday, May 8, 2020) electronically through Bank transfer on Tuesday, May 19, 2020. In case the current Covid-19 lockdown scenario gets extended, the physical warrants/demand drafts, (for shareholders who have not registered their bank mandate with the Company), will be printed and dispatched post removal of the said lockdown. | 06-May-2020 | |
| 28-May-2019 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended a dividend of 225% (Rs. 22.50 per equity share of Rs. 10/- each) for the financial year ended March 31, 2019. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on August 26, 2019. | 01-Aug-2019 | |
| 07-May-2018 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 07, 2018, inter alia, has recommended a dividend of 200% (Rs. 20 per equity share of Rs. 10 each) for the financial year ended March 31, 2018. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on September 11, 2018. | 29-Aug-2018 | |
| 06-May-2017 | D | Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith audited financial results for the quarter and financial year ended March 31, 2017, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 3.30 p.m. and concluded at 5.30 p.m. Further, please be informed that The Board of Directors of the Company has recommended a normal dividend of 150% (Rs. 15 per equity share of Rs. 10 each) and a special dividend of 50% (Rs. 5 per equity share of Rs. 10 each) on account of exceptional income during the year, aggregating to total dividend of 200% (Rs. 20 per equity share of Rs. 10 each) for the financial year ended March 31, 2017. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on September 14, 2017. | 22-Aug-2017 | |
| 06-May-2017 | D | Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith audited financial results for the quarter and financial year ended March 31, 2017, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 3.30 p.m. and concluded at 5.30 p.m. Further, please be informed that The Board of Directors of the Company has recommended a normal dividend of 150% (Rs. 15 per equity share of Rs. 10 each) and a special dividend of 50% (Rs. 5 per equity share of Rs. 10 each) on account of exceptional income during the year, aggregating to total dividend of 200% (Rs. 20 per equity share of Rs. 10 each) for the financial year ended March 31, 2017. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on September 14, 2017. | 22-Aug-2017 | |
| 06-May-2016 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2016, inter alia, have recommended a dividend of Rs. 15.00 per Equity share of Rs. 10/- each (150%) for the financial year ended March 31, 2016. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on July 20, 2016. | 27-Jun-2016 | |
| 05-May-2015 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 05, 2015, inter alia, has recommended a dividend of Rs. 12.50/- per Equity share of Rs. 10/- each (125%) for the financial year ended March 31, 2015. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on July 28, 2015. | 03-Jul-2015 | |
| 25-Nov-2013 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company ('Board') at their meeting held on November 23, 2013 has approved the payment of Interim Dividend of Rs. 360/- per equity share of Rs. 10/- each (3600%) to the shareholders of the Company. The said interim dividend will be paid on December 17, 2013. | 05-Dec-2013 | |
| 14-May-2013 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, inter alia, has recommended a normal dividend of Rs.12.50/- per Equity share of Rs.10/- each (125%) and special dividend of Rs. 20/- per Equity share of Rs. 10/- each (200%) on account of sale of animal health business aggregating to a total dividend of Rs. 32.50/- per Equity share of Rs. 10/- each (325%) for the year ended March 31, 2013, The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on September 12, 2013. | 28-Aug-2013 | |
| 14-May-2013 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, inter alia, has recommended a normal dividend of Rs.12.50/- per Equity share of Rs.10/- each (125%) and special dividend of Rs. 20/- per Equity share of Rs. 10/- each (200%) on account of sale of animal health business aggregating to a total dividend of Rs. 32.50/- per Equity share of Rs. 10/- each (325%) for the year ended March 31, 2013, The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on September 12, 2013. | 28-Aug-2013 | |
| 21-May-2012 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2012, inter alia, recommended a dividend of Rs. 12.50/- per Equity share of Rs. 10 each (125%) for the year ended March 31, 2012. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on August 16, 2012.
| 24-Jul-2012 | |
| 03-May-2011 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 03, 2011, inter alia, has recommended a final dividend of Rs.4.00 per Equity share of Rs. 10 each (40%) for the 16 months period December 01, 2009 to March 31, 2011. The said final dividend shall be paid / dispatched on August 02, 2011. | 08-Jul-2011 | |
| 11-Jan-2011 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 11, 2011, inter alia, declared an Interim Dividend of Rs. 12.50/- per Equity share of Rs. 10 each (125%) for the current financial year ending March 31, 2011, i.e. 16 months period commencing from December 01, 2009 to March 31, 2011. | 20-Jan-2011 | |
| 25-Feb-2010 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2010, inter alia, has recommended a Dividend of Rs. 12.50 per Equity Share of Rs. 10/- each (125%) for the financial year ended November 30, 2009. | 15-Apr-2010 | |
| 31-Jan-2009 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 30, 2009, inter alia, has recommended a dividend of Rs 12.50 per Equity Share of Rs 10/- each (125%) for the financial year ended November 30, 2008. | 31-Mar-2009 | |
| 25-Feb-2008 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2008, inter alia, has recommended total Dividend of Rs 27.50 (Rupees Twenty Seven and paise fifty only) (275%) per Equity Share of Rs 10/- each, for the financial year ended November 30, 2007, being normal dividend of Rs 12.50 (Rupees Twelve and paise fifty only) (125%) per share and additional dividend of Rs 15/- (150%) per equity share, in view of sale of four Consumer Healthcare Brands to Johnson & Johnson Ltd. | 03-Apr-2008 | |
| 25-Feb-2008 | D | Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2008, inter alia, has recommended total Dividend of Rs 27.50 (Rupees Twenty Seven and paise fifty only) (275%) per Equity Share of Rs 10/- each, for the financial year ended November 30, 2007, being normal dividend of Rs 12.50 (Rupees Twelve and paise fifty only) (125%) per share and additional dividend of Rs 15/- (150%) per equity share, in view of sale of four Consumer Healthcare Brands to Johnson & Johnson Ltd. | 03-Apr-2008 | |
| 20-Jan-2007 | D | 225% Final Dividend | 09-Mar-2007 | |
| 20-Jan-2006 | D | 100% Final Dividend | 10-Apr-2006 | |
| 29-Feb-2024 | BC | Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, please find enclosed notice of the Postal Ballot along with explanatory statement.
Pursuant to Regulation 44 of SEBI LODR Regulations, 201 | 30-Mar-2024 | |
| 09-Feb-2024 | BC | Re-appointment of Ms. Meena Ganesh | 08-Mar-2024 | |
| 22-Jan-2024 | BC | Pursuant to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that upon recommendation of the Nomination Remuneration Committee, the Board | 26-Feb-2024 | |
| 31-Jan-2024 | BC | PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve and take on record the Unaudited Financial Results | 09-Feb-2024 | |
| 22-Jan-2024 | BC | Pursuant to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that upon recommendation of the Nomination Remuneration Committee, the Board | 22-Jan-2024 | |